| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.189 | 10.051 | 7.456 | 5.642 | 13.170 | 10.414 | 10.386 | 9.674 | 0 | 0 |
| Total Income - EUR | 12.189 | 10.051 | 7.456 | 5.642 | 13.170 | 10.414 | 10.386 | 9.674 | 0 | 0 |
| Total Expenses - EUR | 12.442 | 14.815 | 14.444 | 13.393 | 16.316 | 14.238 | 13.998 | 12.988 | 40 | 0 |
| Gross Profit/Loss - EUR | -253 | -4.764 | -6.988 | -7.751 | -3.146 | -3.824 | -3.612 | -3.314 | -40 | 0 |
| Net Profit/Loss - EUR | -619 | -4.964 | -7.065 | -7.807 | -3.541 | -4.082 | -4.035 | -3.604 | -40 | 0 |
| Employees | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Adimed Com Prodimpex 2010 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 6.013 | 1.079 | 1.870 | 5.737 | 2.099 | 2.015 | 2.514 | 1.716 | 1.647 | 1.597 |
| Inventories | -39 | -128 | 562 | 4.014 | 747 | 747 | 1.157 | 273 | 274 | 273 |
| Receivables | 5.979 | 986 | 1.154 | 1.471 | 1.257 | 1.169 | 1.141 | 1.171 | 1.305 | 1.256 |
| Cash | 73 | 222 | 154 | 252 | 96 | 99 | 216 | 273 | 69 | 68 |
| Shareholders Funds | -31.020 | -35.668 | -42.130 | -49.155 | -51.744 | -54.846 | -57.664 | -61.447 | -61.301 | -60.958 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 37.033 | 36.747 | 44.000 | 54.892 | 53.865 | 56.862 | 60.178 | 63.164 | 62.948 | 62.555 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Adimed Com Prodimpex 2010 S.r.l.